Phesgo and Tecentriq Performance and Approvals slide image

Phesgo and Tecentriq Performance and Approvals

Core Lab menu expansion driving future growth >240 assays running on >100k installed cobasⓇ serum work area instruments Anti-p53 (CE) Launches in 2021, 2022 and upcoming4 Anti-HEV IgG and Anti-HEV IgM (CE) GAAD² (CE) Fentanyl³ (CE, US) sTfR Gen 22 (CE) CRP4 (CN) Maxi-Multipack RBSS (CE) HBeAg Quant (CE) Interferon Gamma (CE) NT-proBNP diagnosis ICON-RL² (US) EBV EBNA IgG (CE) EBV VCA IgG (CE) EBV IgM (CE) GAAD (CE) NT-proBNP claim extension 1 (CE) TnT-hs claim extension1 (CE) PCT CE claim extension1 (CE) Vit D total III2 (CE & US) Anti-HBe (US) Sirolimus (CN) HBsAg Confirmatory² (CE) Alzh CSF biomarkers (CE) Immuno chemistry assays IGRA SARS-CoV-2 (CE) HCV Duo (CE) Anti-HAV 112 (CN) HBsAg Confirmatory² (US) AFP-L3 (CE) FT4 IV² (CE) Alzh CSF biomarker (US) NT-proBNP STRONG-HF (GL) Cortisol III urine application² (CE) tTAU CSF (Ver 2) Elecsys progesterone Diluent² FT4 IV² (US) IL6 - Claim extension neonatal (CE) Vitamin D total III2 (CN) Clinical chemistry assays Benz 22 (US) NH3L2 (CN) Roche ASTP2/ALTP2 cobas 3032 (CE/US) ASTP2/ALTP2 cobas C 5032 (CE/US) BENZ2² (US) sTfR Gen.22 (CN)2 free PHNY2 Launched in 2021 Launched in 2022 Upcoming Launches 1 Claim extension, 2 Product update; 3 Partner Channel. EBV: Epstein-Barr-Virus; 4 non exhaustive, EBNA: Epstein-Barr virus nuclear antigen, VCA: viral capsid antigens, IgM: Immunoglobulin M, anti-p53: autoantibodies, GAAD: in-vitro diagnostic multivariate index assay, NT-proBNP: N-terminal prohormone of brain natriuretic peptide, TnT-hs: Troponin T-high sensitive, PCT: Procalcitonine, Vit D: vitamin D, Anti-HBe: hepatitis B e antigen (HBeAg), HBsAg: hepatitis B surface antigen, Alzh CSF: Alzheimer's disease Cerebrospinal Fluid, SARS-CoV-2: severe acute respiratory syndrome coronavirus 2, HCV: Hepatitis C virus, Anti-HAV: antibodies against Hepatitis A virus, AFP-L3: Lectin-reactive fraction of alpha-fetoprotein, FT4: Free Thyroxine (T4), HEV: Hepatitis E virus, 39 RBSS: Roche Blood Safety Solution, NT-proBNP STRONG-HF Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testing of Heart Failure Therapies, tTau CSF: total tau protein concentration in human cerebrospinal fluid (CSF), IL6: Interleukin-6, sTfR Gen 2: Soluble Transferrin Receptor Generation 2, CRP4: C-reactive protein generation 4, BENZ: Benzodiazepines, NH3L2: Ammonia Gen.2, ASTP2: aspartate aminotransferase with pyridoxal phosphate activation Gen.2, ALTP2: alanine aminotransferase with pyridoxal phosphate Gen.2, free PHNY2: free phenytoin.
View entire presentation